Who owns GILEAD SCIENCES, INC.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of GILD from SEC Form 13F filings across 2,341 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 2,341 institutions disclosed 1.08B shares of GILEAD SCIENCES, INC. worth $160.43B — about 86.6% of shares outstanding; the largest disclosed holder is BlackRock, Inc.. Source: SEC Form 13F filings, parsed by EvidInvest.
2,341
13F holders
$160.43B
value, 2026 filers
86.6%
of shares outstanding (1.08B sh)
262
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of GILD's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 125.2M | $18.67B | 0.3% | 10.1% | +2.8% |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 81.2M | $12.10B | 0.3% | 6.5% | +0.1% |
| 3 | STATE STREET CORP | 61.0M | $9.09B | 0.3% | 4.9% | -0.4% |
| 4 | FMR LLC | 58.3M | $8.68B | 0.4% | 4.7% | -12.9% |
| 5 | Invesco Ltd. | 38.7M | $5.76B | 0.5% | 3.1% | -2.9% |
| 6 | Capital World Investors | 35.9M | $5.36B | 0.6% | 2.9% | -12.3% |
| 7 | VANGUARD PORTFOLIO MANAGEMENT LLC | 35.7M | $5.32B | 0.2% | 2.9% | +1.0% |
| 8 | GEODE CAPITAL MANAGEMENT, LLC | 30.2M | $4.49B | 0.2% | 2.4% | +0.4% |
| 9 | PRICE T ROWE ASSOCIATES INC /MD/ | 27.7M | $4.12B | 0.4% | 2.2% | -7.8% |
| 10 | Capital Research Global Investors | 24.0M | $3.57B | 0.5% | 1.9% | +23.7% |
| 11 | MORGAN STANLEY | 23.8M | $3.54B | 0.2% | 1.9% | -1.0% |
| 12 | JPMORGAN CHASE & CO | 23.1M | $3.49B | 0.2% | 1.9% | +10.8% |
| 13 | Dodge & Cox | 21.8M | $3.25B | 1.7% | 1.8% | -7.9% |
| 14 | BANK OF AMERICA CORP /DE/ | 19.2M | $2.87B | 0.2% | 1.5% | +3.1% |
| 15 | Bank of New York Mellon Corp | 14.8M | $2.20B | 0.4% | 1.2% | -3.3% |
| 16 | GOLDMAN SACHS GROUP INC | 14.6M | $2.18B | 0.2% | 1.2% | +35.5% |
| 17 | NORTHERN TRUST CORP | 13.7M | $2.05B | 0.2% | 1.1% | -0.7% |
| 18 | UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 12.6M | $1.88B | 0.3% | 1% | -2.7% |
| 19 | WELLINGTON MANAGEMENT GROUP LLP | 12.2M | $1.82B | 0.3% | 1% | -3.7% |
| 20 | MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 11.5M | $1.77B | 0.6% | 0.9% | +72.3% |
| 21 | Amundi | 11.3M | $1.68B | 0.3% | 0.9% | +15.2% |
| 22 | Legal & General Group Plc | 10.4M | $1.55B | 0.3% | 0.8% | -0.2% |
| 23 | DEUTSCHE BANK AG\ | 9.6M | $1.43B | 0.4% | 0.8% | +32.3% |
| 24 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 8.3M | $1.23B | 0.2% | 0.7% | +1.5% |
| 25 | DIMENSIONAL FUND ADVISORS LP | 7.8M | $1.16B | 0.2% | 0.6% | -1.3% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.